STUDY QUESTION: Does a novel heterozygous KHDRBS1 variant, identified using whole-exome sequencing (WES) in two patients with primary ovarian insufficiency (POI) in a pedigree, cause defects in mRNA alternative splicing?
Introduction
Primary ovarian insufficiency (POI), also known as premature ovarian failure or premature menopause, is a severe disorder associated with female infertility. POI is defined as a primary ovarian defect that is detected before age 40 years. It is characterized by premature depletion of ovarian follicles and 4-6 months of amenorrhea, with elevated follicle-stimulating hormone (FSH) levels (>40 IU/L) (Santoro, 2003) . POI affects approximately 1% of women and is heritable in up to 30% of patients (Coulam et al., 1986; Woad et al., 2006) . POI is also genetically heterogeneous, so the molecular mechanism of this disorder has been unclear. Several genes have been reported to contribute to the genetic etiology of POI, including FMR1 (Sullivan et al., 2005) , FSHR (Aittomaki et al., 1995; Bramble et al., 2016) , NOBOX (Qin et al., 2007; Li et al., 2017b) , BMP15 (Di Pasquale et al., 2004) , NR5A1 (Lourenco et al., 2009) and FOXL2 (De Baere et al., 2002) . Recently, whole-exome sequencing (WES) technology, which has been used to identify the genetic causes of familial POI, has identified several new genes associated with POI, including STAG3 (Caburet et al., 2014) , HFM1 (Wang et al., 2014) , MCM8 (AlAsiri et al., 2015) , MCM9 (Wood-Trageser et al., 2014) , MSH5 (Guo et al., 2017) and MSH4 (Carlosama et al., 2017) . These findings indicate that WES is a powerful tool for dissecting the genetic alterations in familial POI.
KHDRBS1, also known as Sam68 (Src-associated substrate during mitosis of 68 kDa), belongs to the large class of heteronuclear ribonucleoprotein particle K (hnRNP K) homology (KH) domain family of RNA-binding proteins involved in signal transduction, pre-mRNA splicing, mRNA translation, cell cycle regulation and apoptosis (Paronetto et al., 2007 (Paronetto et al., , 2010 Rajan et al., 2008; Richard, 2010; Ramakrishnan and Baltimore, 2011) . KHDRBS1 contains one KH domain, which directly contacts single-stranded RNA and harbors additional conserved Nand C-terminal sequences (QUA1 and QUA2 domains, respectively) that are also required for RNA-binding and self-association (Vernet and Artzt, 1997; Lukong and Richard, 2003; Richard, 2010) . Experimental studies in mice revealed that Sam68 deficient female mice are subfertile, which manifests as delayed sexual maturity and a significant reduction in the number of secondary and pre-antral follicles (Bianchi et al., 2010) . These findings suggest an important role for Sam68 in the regulation of female fertility, although the association of KHDRBS1 with female infertility has not been investigated.
Here, we report two patients with POI in a Chinese pedigree. Using WES, we found that the POI patient inherited from her mother a heterozygous missense mutation in KHDRBS1. Using RNA-sequencing and alternative splicing analysis, we demonstrated that this mutation resulted in differential expression of 66 genes and 145 alternative splicing genes compared with wild-type (WT) KHDRBS1. Gene Ontology (GO) analysis of the 145 alternative splicing genes suggested a potential underlying mechanism of the disease pathology. This unique study reports genetic alterations of the KHDRBS1 gene locus that confer a high penetrance susceptibility risk for POI.
Materials and Methods

Participants
The POI patients (one pedigree with 215 idiopathic POI patients) were recruited from the Center for Reproductive Medicine at the First Affiliated Hospital of Anhui Medical University. POI was diagnosed if the patients had had amenorrhea for at least 6 months before 40 years of age and two consecutive FSH measurements >40 IU/L performed 2 months apart. POI patients were excluded from the study if they showed any of the following: karyotypic abnormalities (X chromosome abnormalities and FMR1 premutation), autoimmune disorder, history of radiotherapy and chemotherapy, or pelvic surgery. The proband developed POI at the age of 33 years old in 2010, and her mother developed amenorrhea at the age of 39 years old. The hormone levels of the proband were as follows: FSH, 68.64 IU/L (74.54 IU/L, 2 months later); luteinizing hormone, 42.03 mIU/mL; testosterone, 0.99 nmol/L; estradiol, 83.49 pmol/L; prolactin, 15.03 ng/mL. The proband's sister has borne a child and showed no POI at the last follow-up visit. She is 26 years old now. The control group included 400 Han Chinese women (age > 40 years) who were not diagnosed with POI and had normal menses.
The Ethics Committee of Anhui Medical University and the National Research Institute for Family Planning approved this study. Written informed consent was obtained from each participant.
Whole-exome sequencing
Each patient underwent collection of 5 mL of peripheral blood. WES was carried out as previously described (Li et al., 2016) . Briefly, genomic DNA was isolated from the peripheral blood using a QIAamp DNA Mini Kit (Qiagen, Valencia, CA, USA). Exome capture was prepared using SureSelect Human All Exon V5 Kit (Agilent Technologies, Palo Alto, CA, USA). Multiple parallel sequencing was conducted on a HiSeq 2000 platform (Illunima, Inc, San Diego, CA, USA). Sequence reads were aligned with the human reference genome (hg19) using the Burrows Wheeler Aligner algorithm. Duplicate reads and reads that are mapped to multiple locations in the exome were excluded using SAMtools (www.huslib.org). Single nucleotide variations and small insertions/deletions were identified and quality-filtered using SAMtools. Variants fulfilling the following criteria were retained: (1) missense, nonsense, frame shift or splice site variants; (2) absent or rare (frequency < 1%) in the dbSNP (http://www.ncbi.nlm.nih. gov/snp/), 1000 Genomes (http://browser.1000genomes.org/index.html), ESP6500 (http://evs.gs.washington.edu/EVS/), and Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org/) databases.
Mutational analysis of the KHDRBS1 gene
Mutational analysis was conducted as previously described (Wang et al., 2009) . The nine exons and associated introns of the KHDRBS1 gene were amplified by polymerase chain reaction (PCR) using nine pairs of KHDRBS1 gene specific primers (Supplementary Table SI) .
Vector construction
The full-length human KHDRBS1 coding sequence (1332 base pairs, NCBI transcript ID NM_006559) was amplified by PCR from a commercial plasmid (YouBio, G127068) using specific primers. KHDRBS1 WT and c.460A > G (p.M154V) alleles were subcloned into the pENTR-D-TOPO plasmid. An overlapping PCR was used to generate the p.M154V mutation. The KHDRBS1 WT and p.M154V mutation sequences were recombined into the p2k7 (Suter et al., 2006) Cell culture and plasmid transfection KGN cells, a granulosa cell line, were cultured and passaged as previously described (Nishi et al., 2001) . KGN cells were seeded on six-well plates at 30% cell confluence and transfected with p2k7-KHDRBS1 WT, p.M154V variant or the GFP-negative control plasmids using Lipofectamine 2000 (Thermo Fisher Scientific) (each 1000 ng/well), according to the manufacturer's protocol. Cells were cultured for approximately 2-3 days after transfection and then used in further experiments (described later).
Western blot analysis and real-time quantitative PCR
Western blot analysis and real-time quantitative PCR were performed as previously described (Kee et al., 2009 
RNA-sequencing and data analysis
RNA-sequencing was carried out as previously described (Li et al., 2017a) by Annoroad Gene Technology Co., Ltd. (Beijing, China). Differential gene expression analysis was performed using the R Bioconductor, DESeq2 package, as previously described (Love et al., 2014) . The procedure was based on a negative binomial distribution. Raw read counts were employed to build this model, and the false-discovery rate (FDR) was used to correct for multiple testing errors. Only genes with significant P-values (P < 0.05) and FDR values <0.05 were considered differentially expressed.
The results for differentially expressed genes were further presented using the Matplotlib package in Python (www.matplotlib.org). GO analysis was carried out using the DAVID functional annotation bioinformatics microarray analysis (https://david.ncifcrf.gov).
Splicing analysis from replicate RNAsequencing data
Alternative trans-splicing events between WT and M154V-expressing cells were analyzed using rMATS version 3.2.2 software (Shen et al., 2014) with refGene annotation of hg19. Five types of alternative splicing events (skipped exon, mutually exclusive exon, alternative 5′ splice site, alternative 3′ splice site and retained intron) based on annotated Ensembl genes were tested for an inclusion-level difference of >5%, and the events with an FDR of <0.05 were determined as differential alternative splicing events. Sashimi plots were generated using the Integrated Genomics Viewer (Robinson et al., 2011) .
Results
WES analysis of POI patients in a pedigree
A Chinese pedigree containing POI patients was examined in this study. WES was performed for the POI proband, her mother (who also had POI), and her younger sister. Pedigree analysis suggested the presence of a dominant mode of inheritance associated with POI (Fig. 1A) . We therefore focused on the WES-detected heterozygous mutations identified in the patient. After filtering out polymorphisms with an allele frequency of >1% in the dbSNP, 1000 Genomes, ESP6500 and ExAC databases (Supplementary Table SIII) , we compiled a list of genes harboring heterozygous mutations in both the proband and her mother but that were absent in the proband's sister. Among these 49 genes (Supplementary Table SIV) , taking into consideration changes in conserved amino acids, the published phenotype of knock-out mice and the gene expression profile, we found that KHDRBS1 was highly expressed in the ovaries (Fig. 1D) , and Khdrbs1 knock-out mice exhibited defective follicle development (Bianchi et al., 2010) . Therefore, we hypothesized that the heterozygous mutation in the KHDRBS1 gene was associated with POI. We performed Sanger sequencing and confirmed that the heterozygous mutation in KHDRBS1 (c.460A > G, p.M154V) was present in the proband and her mother, but was absent in her sister and father (Fig. 1A) . Further mutational analysis of the KHDRBS1 gene was conducted in 215 idiopathic POI patients, among whom we found one heterozygous mutation (c.263C > T, p.P88L) in one POI patient (Supplementary Fig.  S1A ). After screening 400 healthy control women, we failed to identify these mutations or other mutations in the KHDRBS1 gene.
In silico analysis of p.M154V and p.P88L mutations
In silico analysis predicted that the KHDRBS1 p.M154V mutation (abbreviated as M154V) is likely a disease-associated mutation according to the Mutation Taster, FATHMM-MKL and PANTHER (Table I) , whereas other online tools predicted this mutation to be benign (Table I ). The p.P88L mutation (abbreviated as P88L) was also predicted to be a disease-associated mutation by Mutation Taster and a damaging mutation by SIFT and PANTHER (Table I ). Neither the c.460A > G or c.263C > T variants were found in the ExAC (http:// exac.broadinstitute.org) and gnomAD (http://gnomad.broadinstitute. org/), indicating the extreme rarity of these two variants (Table I) .
M154 is located in the border region of the maxi-KH domain in the KHDRBS1 protein (Fig. 1B) , and P88 is in the QUA1 domain. The KH domain and its flanking regions (QUA1 and QUA2 domains) are required for RNA-binding, alternative splicing and dimerization (Vernet and Artzt, 1997; Lukong and Richard, 2003; Paronetto et al., 2007; Richard, 2010) . The methionine located at amino acid 154 and the proline located at amino acid 88 in human KHDRBS1 are 100% conserved in species ranging from humans to the tropical clawed frog (Fig. 1C and Supplementary Fig. S1B ), and the conservation scores by PANTHER and GERP also indicated the functional importance of the M154 and P88 sites (Table I) . Thus, we hypothesized that the M154V and P88L mutations may affect RNA-binding and the alternative splicing activity of KHDRBS1.
RNA-sequencing analysis of M154V mutation cells
To test whether the M154V mutation affects RNA-binding and alternative splicing activity, we introduced the M154V-encoding mutation into KHDRBS1 and expressed WT KHDRBS1 and the M154V mutant in KGN cells. Western blot analysis showed that the expression level of the M154V mutant was similar to that of the WT KHDRBS1 protein ( Supplementary Fig. S2A ), which suggested that the M154V mutation did not affect the steady state of KHDRBS1 protein.
We next examined whether the mRNA level and alternative splicing were affected by the M154V mutation at the genome-wide scale. KGN cells were transfected with overexpression vectors carrying GFP (negative control), WT KHDRBS1 or M154V KHDRBS1. The WT and M154V KHDRBS1 mRNA expression levels were similar ( Supplementary Fig.  S2B ). Transcriptome analysis was used to examine the genome-wide expression profiles in M154V and WT cells. In all, 66 genes in the WT KHDRBS1-and M154V-expressing cells were expressed significantly differently in these cells (FDR < 0.05) (Fig. 2A) . Among the 66 genes, 4 (MMP15, PTOV1, SEMA6B, NME3) were randomly selected. Their expression levels were analyzed and confirmed by real-time quantitative PCR. The mRNA levels of these four genes were higher in M154V-expressing cells (Fig. 2B) , which was consistent with the RNA-sequencing results.
The alternative splicing events with WT and M154V KHDRBS1-expressing cells were analyzed using rMATS version 3.2.2 software (Shen et al., 2014) . A total of 237 alternative splicing events (for 145 genes) were significantly different between the WT and M154V-expressing cells (FDR < 0.05) (Supplementary Table SV) . GO analysis of the 145 alternative splicing genes showed that genes in several biological processes (e.g. DNA replication, cellular protein metabolic process, DNA repair) were the alternative splicing genes in M154V KHDRBS1-expressing cells (Fig. 3A) .
We mainly focused, however, on the biological processes of DNA replication and repair, as many genes belonging to these two processes were previously reported to be candidate genes for POI. Thus, ATM, RECQL4, RFC5, POLL, SSRP1, RFC2, WHSC1, PSME4, SMC1A, SMUG1, ALKBH2, CDK2, CHTF18, DNAJC2, MCM4 and ORC2, which are involved in DNA replication and repair processes, were alternatively spliced in M154V-expressing cells. ATM, which encodes a cell cycle checkpoint kinase and is involved in the response to DNA damage, is a well-known POI candidate gene. Also, the loss-of-function mutation of ATM has been associated with ovarian dysgenesis (Miller and Chatten, 1967) . In our data analysis, ATM was found to be alternatively spliced in M154V-expressing cells. Exon 7 of the ATM gene was used less in M154V-expressing cells than in WT KHDRBS1-expressing cells (Fig. 3B ), leading to a frame shift of the ATM open reading frame. Taken together, these findings suggest that the alteration in expression and splicing of a wide range of genes, especially the DNA replication and repair genes, may be associated with the pathology of POI.
Discussion
We report two POI patients, the mother and the elder daughter, in a Chinese family. Pedigree analysis strongly suggested an autosomal dominant mode of inheritance. By WES analysis, rare heterozygous mutation, p.M154V, in the KHDRBS1 gene was identified in the two patients. Functional analysis of the mutation allowed us to identify 66 genes that were differentially expressed in M154V and WT KHDRBS1-expressing cells. Our subsequent analysis showed that 145 of the genes were alternatively spliced in M154V-expressing cells but not in the WT KHDRBS1-expressing cells. GO analysis also showed that the alternative splicing genes related to DNA replication and repair were more prevalent in M154V-expressing cells. This GO result was consistent with the previous finding that mutations in DNA replication and repair genes were closely associated with POI. Therefore, the differentially expressed genes and alternative splicing genes induced by M154V KHDRBS1 expression may explain the underlying mechanism of POI. Previous studies of POI etiology found that mutation of genes involved in DNA replication and repair, e.g. STAG3 (Caburet et al., 2014) , HFM1 (Wang et al., 2014) , 2008) can cause POI. In our study, many DNA replication and repair genes were alternatively spliced in M154V cells. Thus, we propose that the M154V mutation of KHDRBS1 may lead to the alternative splicing of genes involved in DNA replication and repair. This process, in turn, may affect that of DNA repair of granulosa cells and/or oocytes, affecting the quality of the granulosa cells and/or germ cells, finally leading to POI.
In our functional study, the M154V mutation was found to alter the mRNA expression level and alternative splicing. M154V is located in the border region of the maxi-KH domain of KHDRBS1 protein. The M154 site is highly conserved. The KH domain and its flanking regions are required for RNA-binding, alternative splicing and dimerization (Vernet and Artzt, 1997; Lukong and Richard, 2003; Paronetto et al., 2007; Richard, 2010) . Therefore, the M154V mutation may affect RNA-binding, alternative splicing and/or dimerization of KHDRBS1. Further studies are required to validate whether the interaction between KHDRBS1 and mRNA targets is enhanced or attenuated by the M154V mutation.
We also found a single heterozygous mutation, P88L, in one idiopathic POI patient but not in the healthy controls. The P88 site is conserved in various species. The P88L mutation is rare and was not found in the ExAC database. This mutation was predicted as a damaging mutation by two online tools. Therefore, we predict that the P88L mutation also affects the alternative splicing capability of KHDRBS1, as did the M154V mutation. However, further study is needed to clarify whether the P88L mutation exerts the same effects as the M154V mutation.
In summary, our study demonstrated that the heterozygous mutation p.M154V of the KHDRBS1 gene exerted a significant effect on the mRNA expression level and alternative splicing. It may also be a high penetrance susceptibility risk for POI by affecting DNA replication and repair. This finding provides researchers and clinicians with a better understanding of the etiology and molecular mechanism of POI.
Supplementary data
Supplementary data are available at Human Reproduction online. for Family Planning (2017GJZ05), the National Natural Science Foundation of China (31171429) and Beijing Advanced Innovation Center for Structural Biology.
